08:35am Saturday 18 November 2017

Bypassing obstacles of reverse genetics research approaches

Can you explain what makes this novel method so relevant for the research community?
Kristof: For many research questions, a clone library becomes truly useful if we know which mutation or sequence variant is present in each clone. Wellknown examples are collections of yeast strains that each contain a knockout mutation in one gene, or Arabidopsis T-DNA insertion line libraries.

The construction of such pre-characterized libraries of mutants can be extremely valuable, especially in difficult-to-engineer organisms, but often requires huge investments in terms of time and money. We have devised a more efficient alternative: an effective and easy-to-implement parallel sequencing-based approach. Characterizing a 96×96 clone Mycobacterium
bovis BCG transposon insertion library.

You worked with a Mycobacterium mutant library. Will this novel method have implications for
tuberculosis research?
At the moment, large efforts are ongoing in the tuberculosis (TB) research community to generate
genome-wide mutant resources for slow-growing mycobacteria. Our research provides a very versatile and extremely cost-effective tool to construct such resources. We have generated the largest resource of mutants in any strain of the M. tuberculosis complex to date.

These single mutants are now available within our lab for testing and can be provided to any researcher upon request. Moreover, with minor modifications to the setup, this straightforward approach is entirely portable to any ordered library of sequence-tagged biological entities or clone collections.

You demonstrated this approach using a Mycobacterium bovis BCG mutant library, instead of
Mycobacterium tuberculosis, why?
Nico: With M. bovis BCG genetically being over 99% identical to M. tuberculosis, it is a highly
suitable and safer alternative for genetic studies. Moreover, although generated almost a century ago, M. bovis BCG is still the only licensed vaccine against tuberculosis. We and others believe that this vaccine strain has retained properties that can modulate theimmune system and thus prevent a fully protective memory immune response.

By inactivating some of these corresponding genes, we hope to obtain a modified strain that is able to mount an appropriate immune response. This has already been described by our lab in the past using a mutant from the collection with a disruption in the SapM locus. Festjens et al, 2011

Nevertheless, further improvements through additional mutations will probably be required to
progress into clinical trials. To this end, genomewide mutant collections in this particular organism
can be highly valuable to identify more rapidly such additional immunomodulatory genes.

Vandewalle et al., Nat Communications 2015

  • VIB


Share on:
or:

MORE FROM Genetics and Birth Defects

Health news